Table 1.

Socio-demographic and clinical characteristics according to occupational status.

	Occupational Status						Total
	Student		Unemployed		Employed
	No.	%	No.	%	No.	%	No.	%
Sex
Female	25	47.17	17	36.96	56	39.72	98	40.83
Male	28	52.83	29	63.04	85	60.28	142	59.17
Age at the time of the study (years)
18–24	40	75.47	17	36.96	37	26.24	94	39.17
25–29	13	24.53	14	30.43	50	35.46	77	32.08
≥30	0	0	15	32.61	54	38.3	69	28.75
Marital Status
Single	39	73.58	36	78.26	52	36.88	127	52.92
Partnership	14	26.42	10	21.74	68	48.23	92	38.33
Married	0	0	0	0	19	13.47	19	7.92
Separated	0	0	0	0	2	1.42	2	0.83
Offspring
No	53	100	43	93.48	128	90.78	224	93.34
Yes	0	0	3	6.52	13	9.22	16	6.66
Age at the first cancer diagnosis (years)
0–4	14	26.42	15	32.61	35	24.82	64	26.67
5–9	15	28.3	13	28.26	33	23.4	61	25.42
10–18	24	45.28	18	39.13	73	51.77	115	47.92
Period (of the first cancer diagnosis)
1985–1989	0	0	2	4.35	8	5.67	10	4.17
1990–1999	5	9.43	17	36.96	51	36.17	73	30.42
2000–2012	48	90.57	27	58.7	82	58.16	157	65.42
Cancer diagnosis
Hematologic Malignancies	41	77.36	33	71.74	100	70.92	174	72.50
Acute Lymphoblastic Leukemia	19	35.85	15	32.61	53	37.59	87	36.25
Hodgkin Lymphoma	5	9.43	6	13.04	26	18.44	37	15.42
Non-Hodgkin’s Lymphoma	5	9.43	3	6.52	13	9.22	21	8.75
Acute Myeloid Leukemia and myelodysplastic syndrome	11	20.75	8	17.39	7	4.96	26	10.83
Other hematological not specified	1	1.89	1	2.17	1	0.71	3	1.25
Brain tumors	6	11.32	9	19.57	14	9.93	29	12.08
Sarcomas	6	11.32	2	4.35	18	12.77	26	10.83
Others	0	0	2	4.35	9	6.38	11	4.58
Any radiation
No	31	58.49	14	30.43	71	50.35	116	48.33
Yes	22	41.51	32	69.57	70	49.65	124	51.67
Cranial irradiation
No	43	81.13	29	63.04	117	82.98	189	78.75
Yes	10	18.87	17	36.96	24	17.02	51	21.25
Any chemotherapy
No	2	3.77	1	2.17	2	1.42	5	2.08
Yes	51	96.23	45	97.83	139	98.58	235	97.92
Hematopoietic Stem Cell Transplantation
No	36	67.92	26	56.52	105	74.47	167	69.58
Yes	17	32.08	20	43.48	36	25.53	73	30.42
Endocrinological late effects
No	24	45.28	8	17.39	63	44.68	95	39.58
Moderate	28	52.83	28	60.87	73	51.77	129	53.75
Severe	1	1.89	10	21.74	5	3.55	16	5.5
Cardiovascular late effects
No	43	81.13	26	56.52	104	73.76	173	72.08
Moderate	10	18.87	20	43.48	36	25.53	66	27.50
Severe	0	0	0	0	1	0.71	1	0.42
Pulmonary late effects
No	52	98.11	45	97.83	139	98.58	236	98.33
Moderate	1	1.89	0	0	1	0.71	2	0.83
Severe	0	0	1	2.17	1	0.71	2	0.83
Neurological late effects
No	50	94.34	30	65.22	124	87.94	204	85.00
Moderate	2	3.77	7	15.22	12	8.51	21	8.75
Severe	1	1.89	9	19.57	5	3.55	15	6.25
Musculoskeletal late effects
No	47	88.68	42	91.3	126	89.36	215	89.58
Moderate	3	5.66	4	8.7	13	9.22	20	8.33
Severe	3	5.66	0	0	2	1.42	5	2.08
Reproductive/genital late effects
No	31	58.49	22	47.83	95	67.38	148	61.67
Moderate	5	9.43	10	21.74	6	4.26	21	8.75
Severe	17	32.08	14	30.43	40	28.37	71	29.58
Other late effects *
No	48	90.57	31	67.39	121	85.82	200	83.33
Moderate	5	9.43	11	23.91	12	8.51	28	11.67
Severe	0	0	4	8.7	8	5.67	12	5.00
Any Late Effect
No	13	24.53	5	10.87	34	24.11	52	21.67
Yes	40	75.47	41	89.13	107	75.89	188	78.33
Late effects intensity
No late-effects	13	24.53	5	10.87	34	24.11	52	21.67
At least one moderate and no severe	21	39.62	16	34.78	53	37.59	90	37.50
At least one severe	19	35.85	25	54.35	54	38.3	98	40.83
Total	53	100	46	100	141	100	240	100.00

* Auditory-hearing, gastrointestinal, hepatobiliary, hematologic, immunologic, infectious, ocular/visual, renal/urinary late effects.